newsfilter
← Latest News
Business Wire·

VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Q3 marked a meaningful quarter for partnerships with a recently announced prophylactic hepatitis B commercialization collaboration in certain European countries with Valneva, and a clinical collaboration in